# Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

> **NCT00807755** · PHASE1 · TERMINATED · sponsor: **University of California, Davis** · enrollment: 5 (actual)

## Conditions studied

- Lung Cancer
- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** Carboplatin
- **DRUG:** Etoposide
- **DRUG:** RAD001

## Key facts

- **NCT ID:** NCT00807755
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-03
- **Primary completion:** 2010-08
- **Final completion:** 2011-12
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Number of known toxicities observed despite a treatment-naïve population
- **Last updated:** 2018-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00807755

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00807755, "Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors". Retrieved via AI Analytics 2026-09-15 from https://api.ai-analytics.org/clinical/NCT00807755. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*